{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:12:21Z","timestamp":1769170341983,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT04111939"],"award-info":[{"award-number":["NCT04111939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UM1DA049406"],"award-info":[{"award-number":["UM1DA049406"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102933","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:09:37Z","timestamp":1760062177000},"page":"102933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The minivisit method: Adapting opioid-related educational outreach for community pharmacies"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3462-0920","authenticated-orcid":false,"given":"Monica F.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-6563","authenticated-orcid":false,"given":"Patricia R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0115-9147","authenticated-orcid":false,"given":"Laura K.","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2492-1592","authenticated-orcid":false,"given":"Adrienne","family":"Matson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.japh.2025.102933_bib1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2025.102933_bib2","author":"Mott"},{"issue":"6","key":"10.1016\/j.japh.2025.102933_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.2583","article-title":"US community pharmacies and public health\u2014building on the COVID-19 response","volume":"4","author":"Layson-Wolf","year":"2023","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.japh.2025.102933_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.japh.2022.10.004","article-title":"Community pharmacist-provided opioid intervention frequencies and barriers","volume":"63","author":"Nichols","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2025.102933_bib5","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.japh.2019.04.012","article-title":"Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses","volume":"59","author":"Melaragni","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2S","key":"10.1016\/j.japh.2025.102933_bib6","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists' role in opioid overdose: kentucky pharmacists' willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2025.102933_bib7","article-title":"Development of a brief stigma and perceptions questionnaire for pharmacists: an exploratory factor analysis approach in New York State counties enrolled in the HEALing Communities Study","volume":"169","author":"Goddard-Eckrich","year":"2025","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"10.1016\/j.japh.2025.102933_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13722-024-00519-w","article-title":"Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists","volume":"19","author":"Wu","year":"2024","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.japh.2025.102933_bib9","article-title":"The HEALing (helping to end Addiction long-term SM) Communities Study: protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2025.102933_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108325","article-title":"The opioid-overdose reduction continuum of care approach (ORCCA): Evidence-based practices in the HEALing Communities Study","volume":"217","author":"Winhusen","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2025.102933_bib11","doi-asserted-by":"crossref","first-page":"112500","DOI":"10.1016\/j.drugalcdep.2024.112500","article-title":"Medication disposal within reach: assessing implementation of permanent disposal receptacles in community pharmacies","volume":"266","author":"Miracle","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2025.102933_bib13","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2021-7-7","article-title":"Academic detailing interventions for opioid-related outcomes: a scoping review","volume":"10","author":"Kulbokas","year":"2021","journal-title":"Drugs Context"},{"issue":"1","key":"10.1016\/j.japh.2025.102933_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.japh.2019.09.007","article-title":"Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas","volume":"60","author":"Evoy","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2025.102933_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.japh.2022.12.001","article-title":"Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician","volume":"63","author":"Irwin","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2025.102933_bib16","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.japh.2021.01.031","article-title":"Academic detailing with ambulatory pharmacists to support naloxone counseling","volume":"61","author":"Kennedy","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2025.102933_bib17","series-title":"Food, Drug and Cosmetic Act, Kentucky Revised Statutes 217.177","year":"2022"},{"key":"10.1016\/j.japh.2025.102933_bib18","series-title":"Drug Paraphernalia, Kentucky Revised Statutes, 218A.500","year":"2023"},{"issue":"2","key":"10.1016\/j.japh.2025.102933_bib21","doi-asserted-by":"crossref","first-page":"102308","DOI":"10.1016\/j.japh.2024.102308","article-title":"Barriers to and facilitators of buprenorphine dispensing for opioid use disorder: evidence from focus groups in Appalachian Kentucky","volume":"65","author":"Oyler","year":"2025","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:55:21Z","timestamp":1769111721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1544319125006120"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102933","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The minivisit method: Adapting opioid-related educational outreach for community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102933"}}